Found: 30
Select item for more details and to access through your institution.
Definite and indeterminate nonalcoholic steatohepatitis share similar clinical features and prognosis: A longitudinal study of 1893 biopsy‐proven nonalcoholic fatty liver disease subjects.
- Published in:
- Liver International, 2021, v. 41, n. 9, p. 2076, doi. 10.1111/liv.14898
- By:
- Publication type:
- Article
Safety of direct oral anticoagulants in patients with advanced liver disease.
- Published in:
- Liver International, 2021, v. 41, n. 9, p. 2159, doi. 10.1111/liv.14992
- By:
- Publication type:
- Article
Autoimmune biomarkers in porto‐sinusoidal vascular disease: Potential role in its diagnosis and pathophysiology.
- Published in:
- Liver International, 2021, v. 41, n. 9, p. 2171, doi. 10.1111/liv.14997
- By:
- Publication type:
- Article
HBV‐related hepatocellular carcinoma: A call to improve surveillance and linkage to care.
- Published in:
- Liver International, 2021, v. 41, n. 9, p. 2238, doi. 10.1111/liv.15023
- By:
- Publication type:
- Article
Liver involvement in children with SARS‐COV‐2 infection: Two distinct clinical phenotypes caused by the same virus.
- Published in:
- Liver International, 2021, v. 41, n. 9, p. 2068, doi. 10.1111/liv.14887
- By:
- Publication type:
- Article
Rapid development of gingival bleeding after rivaroxaban in a patient with Budd‐Chiari syndrome.
- Published in:
- Liver International, 2021, v. 41, n. 9, p. 2236, doi. 10.1111/liv.15021
- By:
- Publication type:
- Article
Associations between alcohol consumption and hepatic steatosis in the USA.
- Published in:
- Liver International, 2021, v. 41, n. 9, p. 2020, doi. 10.1111/liv.15020
- By:
- Publication type:
- Article
MR elastography to predict haemodynamic response to beta‐blockers—The story is still incomplete.
- Published in:
- Liver International, 2021, v. 41, n. 9, p. 2235, doi. 10.1111/liv.15015
- By:
- Publication type:
- Article
Outcomes and potential surrogate markers for future clinical trials of non‐alcoholic steatohepatitis cirrhosis.
- Published in:
- Liver International, 2021, v. 41, n. 9, p. 1999, doi. 10.1111/liv.15013
- By:
- Publication type:
- Article
Limited efficacy of atezolizumab and bevacizumab for hepatocellular carcinoma previously treated with tyrosine kinase inhibitor.
- Published in:
- Liver International, 2021, v. 41, n. 9, p. 2233, doi. 10.1111/liv.15010
- By:
- Publication type:
- Article
Management of liver disease in Italy after one year of the SARS‐CoV‐2 pandemic: A web‐based survey.
- Published in:
- Liver International, 2021, v. 41, n. 9, p. 2228, doi. 10.1111/liv.14998
- By:
- Publication type:
- Article
Estrogens in polycystic liver disease: A target for future therapies?
- Published in:
- Liver International, 2021, v. 41, n. 9, p. 2009, doi. 10.1111/liv.14986
- By:
- Publication type:
- Article
Using MR elastography to assess portal hypertension and response to beta‐blockers in patients with cirrhosis.
- Published in:
- Liver International, 2021, v. 41, n. 9, p. 2149, doi. 10.1111/liv.14981
- By:
- Publication type:
- Article
COVID‐19 and the liver: A 2021 update.
- Published in:
- Liver International, 2021, v. 41, n. 9, p. 1988, doi. 10.1111/liv.14984
- By:
- Publication type:
- Article
A genetic variant in toll‐like receptor 5 is linked to chemokine levels and hepatocellular carcinoma in steatohepatitis.
- Published in:
- Liver International, 2021, v. 41, n. 9, p. 2139, doi. 10.1111/liv.14980
- By:
- Publication type:
- Article
Hepatitis C elimination in Sweden: Progress, challenges and opportunities for growth in the time of COVID‐19.
- Published in:
- Liver International, 2021, v. 41, n. 9, p. 2024, doi. 10.1111/liv.14978
- By:
- Publication type:
- Article
Inhibiting xCT/SLC7A11 induces ferroptosis of myofibroblastic hepatic stellate cells but exacerbates chronic liver injury.
- Published in:
- Liver International, 2021, v. 41, n. 9, p. 2214, doi. 10.1111/liv.14945
- By:
- Publication type:
- Article
Evaluation of cardiovascular events in patients with hepatocellular carcinoma treated with sorafenib in the clinical practice. The CARDIO‐SOR study.
- Published in:
- Liver International, 2021, v. 41, n. 9, p. 2200, doi. 10.1111/liv.14941
- By:
- Publication type:
- Article
Kinetics of the neutrophil‐lymphocyte ratio during PD‐1 inhibition as a prognostic factor in advanced hepatocellular carcinoma.
- Published in:
- Liver International, 2021, v. 41, n. 9, p. 2189, doi. 10.1111/liv.14932
- By:
- Publication type:
- Article
Effects of intragastric balloon in patients with nonalcoholic fatty liver disease and advanced fibrosis.
- Published in:
- Liver International, 2021, v. 41, n. 9, p. 2112, doi. 10.1111/liv.14917
- By:
- Publication type:
- Article
Effects of lifestyle interventions on epigenetic signatures of liver fat: Central randomized controlled trial.
- Published in:
- Liver International, 2021, v. 41, n. 9, p. 2101, doi. 10.1111/liv.14916
- By:
- Publication type:
- Article
Long‐term evolution of LI‐RADS observations in HCV‐related cirrhosis treated with direct‐acting antivirals.
- Published in:
- Liver International, 2021, v. 41, n. 9, p. 2179, doi. 10.1111/liv.14914
- By:
- Publication type:
- Article
Diagnostic accuracy of fibrosis tests in children with non‐alcoholic fatty liver disease: A systematic review.
- Published in:
- Liver International, 2021, v. 41, n. 9, p. 2087, doi. 10.1111/liv.14908
- By:
- Publication type:
- Article
A nonbile acid farnesoid X receptor agonist tropifexor potently inhibits cholestatic liver injury and fibrosis by modulating the gut–liver axis.
- Published in:
- Liver International, 2021, v. 41, n. 9, p. 2117, doi. 10.1111/liv.14906
- By:
- Publication type:
- Article
Over time evaluation of glycaemic control in direct‐acting antiviral‐treated hepatitis C virus/diabetic individuals with chronic hepatitis or with cirrhosis.
- Published in:
- Liver International, 2021, v. 41, n. 9, p. 2059, doi. 10.1111/liv.14905
- By:
- Publication type:
- Article
Efficacy and safety of peginterferon alpha monotherapy in Chinese inactive chronic hepatitis B virus carriers.
- Published in:
- Liver International, 2021, v. 41, n. 9, p. 2032, doi. 10.1111/liv.14897
- By:
- Publication type:
- Article
EpCam is required for maintaining the integrity of the biliary epithelium.
- Published in:
- Liver International, 2021, v. 41, n. 9, p. 2132, doi. 10.1111/liv.14891
- By:
- Publication type:
- Article
The impact of hepatitis B surface antigen on natural killer cells in patients with chronic hepatitis B virus infection.
- Published in:
- Liver International, 2021, v. 41, n. 9, p. 2046, doi. 10.1111/liv.14885
- By:
- Publication type:
- Article
Primary yolk sac tumour of liver.
- Published in:
- Liver International, 2021, v. 41, n. 9, p. 2212, doi. 10.1111/liv.14841
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Liver International, 2021, v. 41, n. 9, p. 1983, doi. 10.1111/liv.14528
- Publication type:
- Article